

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 6.68803604 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.68803604 |
| 3 | nuclear pore complex assembly (GO:0051292) | 6.48908201 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.41274883 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.41274883 |
| 6 | aromatic amino acid family catabolic process (GO:0009074) | 6.13746929 |
| 7 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.91609065 |
| 8 | kynurenine metabolic process (GO:0070189) | 5.77101176 |
| 9 | indole-containing compound catabolic process (GO:0042436) | 5.70441659 |
| 10 | indolalkylamine catabolic process (GO:0046218) | 5.70441659 |
| 11 | tryptophan catabolic process (GO:0006569) | 5.70441659 |
| 12 | urea metabolic process (GO:0019627) | 5.70336925 |
| 13 | urea cycle (GO:0000050) | 5.70336925 |
| 14 | nuclear pore organization (GO:0006999) | 5.56953737 |
| 15 | alpha-linolenic acid metabolic process (GO:0036109) | 5.49755055 |
| 16 | regulation of RNA export from nucleus (GO:0046831) | 5.43436755 |
| 17 | tryptophan metabolic process (GO:0006568) | 5.41885203 |
| 18 | bile acid biosynthetic process (GO:0006699) | 5.39198870 |
| 19 | glyoxylate metabolic process (GO:0046487) | 5.30598091 |
| 20 | negative regulation of fibrinolysis (GO:0051918) | 5.26806540 |
| 21 | cysteine metabolic process (GO:0006534) | 5.21928299 |
| 22 | complement activation, alternative pathway (GO:0006957) | 5.21579410 |
| 23 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.18853613 |
| 24 | protein carboxylation (GO:0018214) | 5.18853613 |
| 25 | regulation of protein activation cascade (GO:2000257) | 5.16543732 |
| 26 | nitrogen cycle metabolic process (GO:0071941) | 5.14020693 |
| 27 | high-density lipoprotein particle remodeling (GO:0034375) | 5.10520000 |
| 28 | sulfur amino acid catabolic process (GO:0000098) | 5.07520231 |
| 29 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.94839234 |
| 30 | serine family amino acid catabolic process (GO:0009071) | 4.93450278 |
| 31 | regulation of fibrinolysis (GO:0051917) | 4.92353782 |
| 32 | regulation of complement activation (GO:0030449) | 4.83510247 |
| 33 | protoporphyrinogen IX metabolic process (GO:0046501) | 4.78180128 |
| 34 | homocysteine metabolic process (GO:0050667) | 4.75945952 |
| 35 | lysine catabolic process (GO:0006554) | 4.75660452 |
| 36 | lysine metabolic process (GO:0006553) | 4.75660452 |
| 37 | mitotic sister chromatid cohesion (GO:0007064) | 4.72353022 |
| 38 | bile acid metabolic process (GO:0008206) | 4.69315089 |
| 39 | regulation of triglyceride catabolic process (GO:0010896) | 4.67132230 |
| 40 | reverse cholesterol transport (GO:0043691) | 4.57584716 |
| 41 | amino-acid betaine metabolic process (GO:0006577) | 4.53111840 |
| 42 | iron ion import (GO:0097286) | 4.50210371 |
| 43 | phospholipid efflux (GO:0033700) | 4.49176243 |
| 44 | negative regulation of cholesterol transport (GO:0032375) | 4.45089529 |
| 45 | negative regulation of sterol transport (GO:0032372) | 4.45089529 |
| 46 | triglyceride homeostasis (GO:0070328) | 4.41670934 |
| 47 | acylglycerol homeostasis (GO:0055090) | 4.41670934 |
| 48 | regulation of nucleobase-containing compound transport (GO:0032239) | 4.40538041 |
| 49 | aromatic amino acid family metabolic process (GO:0009072) | 4.40168197 |
| 50 | pore complex assembly (GO:0046931) | 4.39016011 |
| 51 | plasma lipoprotein particle remodeling (GO:0034369) | 4.36463326 |
| 52 | protein-lipid complex remodeling (GO:0034368) | 4.36463326 |
| 53 | macromolecular complex remodeling (GO:0034367) | 4.36463326 |
| 54 | histone H3-K36 demethylation (GO:0070544) | 4.30907209 |
| 55 | glycine metabolic process (GO:0006544) | 4.27081894 |
| 56 | alpha-amino acid catabolic process (GO:1901606) | 4.24496721 |
| 57 | tyrosine metabolic process (GO:0006570) | 4.23512763 |
| 58 | bile acid and bile salt transport (GO:0015721) | 4.20535710 |
| 59 | regulation of cholesterol esterification (GO:0010872) | 4.20219403 |
| 60 | regulation of cholesterol homeostasis (GO:2000188) | 4.18449058 |
| 61 | plasma lipoprotein particle clearance (GO:0034381) | 4.15397731 |
| 62 | phospholipid homeostasis (GO:0055091) | 4.10180104 |
| 63 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.09114810 |
| 64 | cholesterol efflux (GO:0033344) | 4.03772135 |
| 65 | cellular glucuronidation (GO:0052695) | 4.03591214 |
| 66 | glutamate metabolic process (GO:0006536) | 3.96884191 |
| 67 | serine family amino acid metabolic process (GO:0009069) | 3.96488907 |
| 68 | plasma lipoprotein particle assembly (GO:0034377) | 3.96065868 |
| 69 | indolalkylamine metabolic process (GO:0006586) | 3.95273885 |
| 70 | pre-miRNA processing (GO:0031054) | 3.95198775 |
| 71 | cellular modified amino acid catabolic process (GO:0042219) | 3.95153834 |
| 72 | ethanol oxidation (GO:0006069) | 3.90290562 |
| 73 | imidazole-containing compound metabolic process (GO:0052803) | 3.90175764 |
| 74 | cellular amino acid catabolic process (GO:0009063) | 3.89848437 |
| 75 | cellular ketone body metabolic process (GO:0046950) | 3.83916775 |
| 76 | benzene-containing compound metabolic process (GO:0042537) | 3.79449089 |
| 77 | drug catabolic process (GO:0042737) | 3.77681175 |
| 78 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.77577873 |
| 79 | positive regulation of lipid catabolic process (GO:0050996) | 3.76783390 |
| 80 | amine catabolic process (GO:0009310) | 3.76213712 |
| 81 | cellular biogenic amine catabolic process (GO:0042402) | 3.76213712 |
| 82 | fibrinolysis (GO:0042730) | 3.71917096 |
| 83 | coenzyme catabolic process (GO:0009109) | 3.70948381 |
| 84 | regulation of bile acid biosynthetic process (GO:0070857) | 3.68112825 |
| 85 | 2-oxoglutarate metabolic process (GO:0006103) | 3.67523638 |
| 86 | complement activation, classical pathway (GO:0006958) | 3.67108524 |
| 87 | cholesterol homeostasis (GO:0042632) | 3.66843638 |
| 88 | protein-lipid complex assembly (GO:0065005) | 3.66241277 |
| 89 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 3.66223836 |
| 90 | regulation of histone H3-K27 methylation (GO:0061085) | 3.66191007 |
| 91 | serine family amino acid biosynthetic process (GO:0009070) | 3.65419620 |
| 92 | sterol homeostasis (GO:0055092) | 3.63528328 |
| 93 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.62351643 |
| 94 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.62351643 |
| 95 | complement activation (GO:0006956) | 3.61851194 |
| 96 | mitotic chromosome condensation (GO:0007076) | 3.55855172 |
| 97 | acetyl-CoA metabolic process (GO:0006084) | 3.55109765 |
| 98 | arginine metabolic process (GO:0006525) | 3.54186166 |
| 99 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.53555670 |
| 100 | lipoprotein metabolic process (GO:0042157) | 3.53405449 |
| 101 | negative regulation of lipase activity (GO:0060192) | 3.51553225 |
| 102 | negative regulation of histone methylation (GO:0031061) | 3.50963797 |
| 103 | glucuronate metabolic process (GO:0019585) | 3.46111286 |
| 104 | uronic acid metabolic process (GO:0006063) | 3.46111286 |
| 105 | cytoplasmic mRNA processing body assembly (GO:0033962) | 3.45686086 |
| 106 | protein activation cascade (GO:0072376) | 3.45482194 |
| 107 | plasma lipoprotein particle organization (GO:0071827) | 3.44734528 |
| 108 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.43767868 |
| 109 | cytolysis (GO:0019835) | 3.41994743 |
| 110 | low-density lipoprotein particle remodeling (GO:0034374) | 3.41374392 |
| 111 | organic acid catabolic process (GO:0016054) | 3.40627327 |
| 112 | carboxylic acid catabolic process (GO:0046395) | 3.40627327 |
| 113 | DNA unwinding involved in DNA replication (GO:0006268) | 3.39379568 |
| 114 | intestinal cholesterol absorption (GO:0030299) | 3.38653991 |
| 115 | urate metabolic process (GO:0046415) | 3.36881652 |
| 116 | interkinetic nuclear migration (GO:0022027) | 3.33107593 |
| 117 | carnitine metabolic process (GO:0009437) | 3.32920193 |
| 118 | embryonic process involved in female pregnancy (GO:0060136) | 3.26798121 |
| 119 | negative regulation of DNA repair (GO:0045738) | 3.23051391 |
| 120 | positive regulation of transcription from RNA polymerase III promoter (GO:0045945) | 3.22284169 |
| 121 | monoubiquitinated protein deubiquitination (GO:0035520) | 3.10697932 |
| 122 | mRNA stabilization (GO:0048255) | 3.06462982 |
| 123 | RNA stabilization (GO:0043489) | 3.06462982 |
| 124 | carnitine shuttle (GO:0006853) | 3.05955005 |
| 125 | erythrocyte development (GO:0048821) | 2.96951348 |
| 126 | definitive hemopoiesis (GO:0060216) | 2.96055446 |
| 127 | porphyrin-containing compound biosynthetic process (GO:0006779) | 2.95060873 |
| 128 | COPII vesicle coating (GO:0048208) | 2.91628306 |
| 129 | DNA duplex unwinding (GO:0032508) | 2.88383593 |
| 130 | regulation of histone H3-K9 methylation (GO:0051570) | 2.83581812 |
| 131 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.81712140 |
| 132 | fatty acid transmembrane transport (GO:1902001) | 2.81655166 |
| 133 | N-terminal protein amino acid acetylation (GO:0006474) | 2.81308361 |
| 134 | biotin metabolic process (GO:0006768) | 2.79623917 |
| 135 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.78615811 |
| 136 | DNA geometric change (GO:0032392) | 2.73512610 |
| 137 | erythrocyte maturation (GO:0043249) | 2.70688073 |
| 138 | fatty acid homeostasis (GO:0055089) | 2.69925409 |
| 139 | DNA topological change (GO:0006265) | 2.69012719 |
| 140 | regulation of histone H3-K4 methylation (GO:0051569) | 2.66814807 |
| 141 | carnitine transmembrane transport (GO:1902603) | 2.64239998 |
| 142 | carnitine transport (GO:0015879) | 2.63018750 |
| 143 | amino-acid betaine transport (GO:0015838) | 2.63018750 |
| 144 | mitotic nuclear envelope disassembly (GO:0007077) | 2.62922600 |
| 145 | histone H3-K4 methylation (GO:0051568) | 2.61564900 |
| 146 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.60957779 |
| 147 | NLS-bearing protein import into nucleus (GO:0006607) | 2.60602028 |
| 148 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 2.60212329 |
| 149 | histone lysine demethylation (GO:0070076) | 2.59953929 |
| 150 | membrane disassembly (GO:0030397) | 2.59428960 |
| 151 | nuclear envelope disassembly (GO:0051081) | 2.59428960 |
| 152 | regulation of histone methylation (GO:0031060) | 2.56657426 |
| 153 | skeletal muscle adaptation (GO:0043501) | 2.55803988 |
| 154 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.55589734 |
| 155 | positive regulation of DNA-templated transcription, initiation (GO:2000144) | 2.53309218 |
| 156 | protein export from nucleus (GO:0006611) | 2.52142614 |
| 157 | corticosteroid receptor signaling pathway (GO:0031958) | 2.50596534 |
| 158 | histone H3-K9 demethylation (GO:0033169) | 2.48466091 |
| 159 | porphyrin-containing compound metabolic process (GO:0006778) | 2.48352564 |
| 160 | tetrapyrrole biosynthetic process (GO:0033014) | 2.46432111 |
| 161 | intestinal absorption (GO:0050892) | 2.46376286 |
| 162 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.44143382 |
| 163 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.43935970 |
| 164 | DNA conformation change (GO:0071103) | 2.41945070 |
| 165 | peptidyl-lysine dimethylation (GO:0018027) | 2.41768732 |
| 166 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.41470796 |
| 167 | intestinal epithelial cell development (GO:0060576) | 2.41166189 |
| 168 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.40982876 |
| 169 | quaternary ammonium group transport (GO:0015697) | 2.40540181 |
| 170 | histone demethylation (GO:0016577) | 2.40489981 |
| 171 | protein localization to chromosome, centromeric region (GO:0071459) | 2.40350866 |
| 172 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.39563551 |
| 173 | cellular hyperosmotic response (GO:0071474) | 2.39328259 |
| 174 | histone-serine phosphorylation (GO:0035404) | 2.38138150 |
| 175 | regulation of mRNA stability (GO:0043488) | 2.37663846 |
| 176 | positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261) | 2.37504793 |
| 177 | regulation of translational fidelity (GO:0006450) | 2.36818012 |
| 178 | oxygen transport (GO:0015671) | 2.35689650 |
| 179 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787) | 2.35175637 |
| 180 | exogenous drug catabolic process (GO:0042738) | 2.34583201 |
| 181 | sister chromatid segregation (GO:0000819) | 2.34213972 |
| 182 | protein-lipid complex subunit organization (GO:0071825) | 2.33459258 |
| 183 | positive regulation of gluconeogenesis (GO:0045722) | 2.32543423 |
| 184 | histone H3-K4 trimethylation (GO:0080182) | 2.31836541 |
| 185 | DNA replication initiation (GO:0006270) | 2.31536420 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 8.51258800 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.48637229 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.66219844 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.97247499 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.64787705 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.50494589 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.38014953 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.05782618 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.98683649 |
| 10 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.82292205 |
| 11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.16858730 |
| 12 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 2.81503026 |
| 13 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.33712893 |
| 14 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.24933533 |
| 15 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.11468555 |
| 16 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.05059103 |
| 17 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.4585571 |
| 18 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.97476401 |
| 19 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.96026024 |
| 20 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.92320420 |
| 21 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.85241908 |
| 22 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.83394316 |
| 23 | * CHD1_26751641_Chip-Seq_LNCaP_Human | 1.78001201 |
| 24 | GATA1_22025678_ChIP-Seq_K562_Human | 1.76327511 |
| 25 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.69851468 |
| 26 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.62308652 |
| 27 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.61647874 |
| 28 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.48255165 |
| 29 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.47749634 |
| 30 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.46788095 |
| 31 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.45233531 |
| 32 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.42954707 |
| 33 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.39847756 |
| 34 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.37086934 |
| 35 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.35912095 |
| 36 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.33337667 |
| 37 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.31765111 |
| 38 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.29520384 |
| 39 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.27395720 |
| 40 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.26033389 |
| 41 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.25410915 |
| 42 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.25359629 |
| 43 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.20280639 |
| 44 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.19363402 |
| 45 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.19330295 |
| 46 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.19267972 |
| 47 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.18388009 |
| 48 | MYB_26560356_Chip-Seq_TH1_Human | 1.18228917 |
| 49 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.15474733 |
| 50 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.15053475 |
| 51 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.14977768 |
| 52 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.14304969 |
| 53 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.12148552 |
| 54 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.12097241 |
| 55 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 1.10669014 |
| 56 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.10126760 |
| 57 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.08005498 |
| 58 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.07945636 |
| 59 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.07528452 |
| 60 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.05810555 |
| 61 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.04674706 |
| 62 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03903942 |
| 63 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.03332728 |
| 64 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.01967814 |
| 65 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.01537185 |
| 66 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01489007 |
| 67 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.00590094 |
| 68 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.00031176 |
| 69 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.98586988 |
| 70 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.97184587 |
| 71 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.97025392 |
| 72 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.96888183 |
| 73 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.96888183 |
| 74 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.96443053 |
| 75 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.96088600 |
| 76 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.94783058 |
| 77 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.94531788 |
| 78 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.94226381 |
| 79 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.93138034 |
| 80 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.92490831 |
| 81 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.92196269 |
| 82 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.92081507 |
| 83 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.91949676 |
| 84 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.91786074 |
| 85 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.91724659 |
| 86 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.91545621 |
| 87 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91172536 |
| 88 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.90685051 |
| 89 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.89951881 |
| 90 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.89197635 |
| 91 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.88959876 |
| 92 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.87431638 |
| 93 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.84291639 |
| 94 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.83985944 |
| 95 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.82478866 |
| 96 | * FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.81929349 |
| 97 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.80162392 |
| 98 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.80026472 |
| 99 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.79635038 |
| 100 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.79376615 |
| 101 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.78898609 |
| 102 | MYC_22102868_ChIP-Seq_BL_Human | 0.77729916 |
| 103 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.76990358 |
| 104 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.76663744 |
| 105 | GATA1_19941826_ChIP-Seq_K562_Human | 0.76505754 |
| 106 | ATF3_27146783_Chip-Seq_COLON_Human | 0.76052211 |
| 107 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.75860608 |
| 108 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 0.73093002 |
| 109 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.72593109 |
| 110 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.72199124 |
| 111 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.72039074 |
| 112 | GATA2_19941826_ChIP-Seq_K562_Human | 0.71695410 |
| 113 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.70941990 |
| 114 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.69318552 |
| 115 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.69318552 |
| 116 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.69255241 |
| 117 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.69237147 |
| 118 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.68980614 |
| 119 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.67051756 |
| 120 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.65723466 |
| 121 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.63589220 |
| 122 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.63223489 |
| 123 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.62748704 |
| 124 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.61582986 |
| 125 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 0.61488873 |
| 126 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.60744672 |
| 127 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.60220831 |
| 128 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.59587179 |
| 129 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.59280532 |
| 130 | * RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.59201822 |
| 131 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.59120562 |
| 132 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.58600127 |
| 133 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.58439541 |
| 134 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.58392949 |
| 135 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.58206163 |
| 136 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.57031364 |
| 137 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.56813724 |
| 138 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.56359021 |
| 139 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.55804789 |
| 140 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.55676488 |
| 141 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.55180958 |
| 142 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.54928669 |
| 143 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.54362886 |
| 144 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.53903146 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.45936086 |
| 2 | MP0005360_urolithiasis | 7.07772827 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.80740432 |
| 4 | MP0005365_abnormal_bile_salt | 5.61855919 |
| 5 | MP0008057_abnormal_DNA_replication | 4.92232147 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 4.45432052 |
| 7 | MP0003252_abnormal_bile_duct | 3.98223311 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 3.49744989 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.39807005 |
| 10 | MP0009840_abnormal_foam_cell | 3.19749701 |
| 11 | MP0002009_preneoplasia | 3.10737702 |
| 12 | MP0005083_abnormal_biliary_tract | 2.77309468 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.64224847 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.51111303 |
| 15 | MP0003705_abnormal_hypodermis_morpholog | 2.47121201 |
| 16 | MP0004147_increased_porphyrin_level | 2.44771955 |
| 17 | MP0005332_abnormal_amino_acid | 2.36364653 |
| 18 | MP0000609_abnormal_liver_physiology | 2.19982779 |
| 19 | MP0003111_abnormal_nucleus_morphology | 2.16717066 |
| 20 | MP0003195_calcinosis | 2.10689966 |
| 21 | MP0002138_abnormal_hepatobiliary_system | 1.98051971 |
| 22 | MP0004019_abnormal_vitamin_homeostasis | 1.94629210 |
| 23 | MP0002118_abnormal_lipid_homeostasis | 1.93493619 |
| 24 | MP0003693_abnormal_embryo_hatching | 1.92515446 |
| 25 | MP0002396_abnormal_hematopoietic_system | 1.85720432 |
| 26 | MP0010094_abnormal_chromosome_stability | 1.83171135 |
| 27 | MP0004957_abnormal_blastocyst_morpholog | 1.79941953 |
| 28 | MP0005451_abnormal_body_composition | 1.76417834 |
| 29 | MP0003890_abnormal_embryonic-extraembry | 1.74232788 |
| 30 | MP0003941_abnormal_skin_development | 1.72948075 |
| 31 | MP0003646_muscle_fatigue | 1.71968362 |
| 32 | MP0010307_abnormal_tumor_latency | 1.71867874 |
| 33 | MP0005319_abnormal_enzyme/_coenzyme | 1.71430425 |
| 34 | MP0003868_abnormal_feces_composition | 1.62324131 |
| 35 | MP0001730_embryonic_growth_arrest | 1.61327010 |
| 36 | MP0004233_abnormal_muscle_weight | 1.59484483 |
| 37 | MP0003077_abnormal_cell_cycle | 1.56050764 |
| 38 | MP0010234_abnormal_vibrissa_follicle | 1.55162589 |
| 39 | MP0003984_embryonic_growth_retardation | 1.52817262 |
| 40 | MP0002088_abnormal_embryonic_growth/wei | 1.52327522 |
| 41 | MP0005409_darkened_coat_color | 1.49256589 |
| 42 | MP0002254_reproductive_system_inflammat | 1.45973527 |
| 43 | MP0004145_abnormal_muscle_electrophysio | 1.45215105 |
| 44 | MP0001672_abnormal_embryogenesis/_devel | 1.41691202 |
| 45 | MP0005380_embryogenesis_phenotype | 1.41691202 |
| 46 | MP0002877_abnormal_melanocyte_morpholog | 1.40299733 |
| 47 | MP0002086_abnormal_extraembryonic_tissu | 1.37977845 |
| 48 | MP0000350_abnormal_cell_proliferation | 1.29761991 |
| 49 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.26736799 |
| 50 | MP0000598_abnormal_liver_morphology | 1.23383368 |
| 51 | MP0009643_abnormal_urine_homeostasis | 1.22883908 |
| 52 | MP0001764_abnormal_homeostasis | 1.22733388 |
| 53 | MP0004808_abnormal_hematopoietic_stem | 1.21863988 |
| 54 | MP0003300_gastrointestinal_ulcer | 1.20921497 |
| 55 | MP0001697_abnormal_embryo_size | 1.20425236 |
| 56 | MP0004036_abnormal_muscle_relaxation | 1.20285671 |
| 57 | MP0003763_abnormal_thymus_physiology | 1.18366662 |
| 58 | MP0003656_abnormal_erythrocyte_physiolo | 1.15938377 |
| 59 | MP0005670_abnormal_white_adipose | 1.14027780 |
| 60 | MP0010630_abnormal_cardiac_muscle | 1.13216823 |
| 61 | MP0003221_abnormal_cardiomyocyte_apopto | 1.12271147 |
| 62 | MP0010368_abnormal_lymphatic_system | 1.12224509 |
| 63 | MP0004087_abnormal_muscle_fiber | 1.09971791 |
| 64 | MP0009697_abnormal_copulation | 1.05602827 |
| 65 | MP0000747_muscle_weakness | 1.05599651 |
| 66 | MP0005647_abnormal_sex_gland | 1.05356954 |
| 67 | MP0000383_abnormal_hair_follicle | 1.04865364 |
| 68 | MP0004197_abnormal_fetal_growth/weight/ | 1.04196749 |
| 69 | MP0004264_abnormal_extraembryonic_tissu | 1.02406236 |
| 70 | MP0002080_prenatal_lethality | 1.00529627 |
| 71 | MP0003950_abnormal_plasma_membrane | 1.00217127 |
| 72 | MP0002006_tumorigenesis | 1.00057910 |
| 73 | MP0004130_abnormal_muscle_cell | 0.99499006 |
| 74 | MP0009053_abnormal_anal_canal | 0.98041365 |
| 75 | MP0003011_delayed_dark_adaptation | 0.97491581 |
| 76 | MP0001873_stomach_inflammation | 0.96714513 |
| 77 | MP0005375_adipose_tissue_phenotype | 0.95282640 |
| 78 | MP0009703_decreased_birth_body | 0.94984551 |
| 79 | MP0009763_increased_sensitivity_to | 0.94637584 |
| 80 | MP0004084_abnormal_cardiac_muscle | 0.94170077 |
| 81 | MP0000604_amyloidosis | 0.93998973 |
| 82 | MP0002796_impaired_skin_barrier | 0.92784245 |
| 83 | MP0009764_decreased_sensitivity_to | 0.88711531 |
| 84 | MP0005187_abnormal_penis_morphology | 0.87933711 |
| 85 | MP0002084_abnormal_developmental_patter | 0.86228660 |
| 86 | MP0006138_congestive_heart_failure | 0.85252592 |
| 87 | MP0002971_abnormal_brown_adipose | 0.83387458 |
| 88 | MP0005666_abnormal_adipose_tissue | 0.81204837 |
| 89 | MP0005408_hypopigmentation | 0.81191830 |
| 90 | MP0005220_abnormal_exocrine_pancreas | 0.79109184 |
| 91 | MP0008469_abnormal_protein_level | 0.78116733 |
| 92 | MP0000313_abnormal_cell_death | 0.77427485 |
| 93 | MP0005621_abnormal_cell_physiology | 0.76646588 |
| 94 | MP0003186_abnormal_redox_activity | 0.75970262 |
| 95 | MP0000759_abnormal_skeletal_muscle | 0.75476219 |
| 96 | MP0009642_abnormal_blood_homeostasis | 0.75269637 |
| 97 | MP0004381_abnormal_hair_follicle | 0.74384246 |
| 98 | MP0001545_abnormal_hematopoietic_system | 0.74249366 |
| 99 | MP0005397_hematopoietic_system_phenotyp | 0.74249366 |
| 100 | MP0005334_abnormal_fat_pad | 0.74226407 |
| 101 | MP0002060_abnormal_skin_morphology | 0.72987939 |
| 102 | MP0002106_abnormal_muscle_physiology | 0.72507930 |
| 103 | MP0008007_abnormal_cellular_replicative | 0.72044384 |
| 104 | MP0008058_abnormal_DNA_repair | 0.71795262 |
| 105 | MP0004185_abnormal_adipocyte_glucose | 0.71641063 |
| 106 | MP0003453_abnormal_keratinocyte_physiol | 0.70765057 |
| 107 | MP0005636_abnormal_mineral_homeostasis | 0.69828751 |
| 108 | MP0002078_abnormal_glucose_homeostasis | 0.69514600 |
| 109 | MP0002085_abnormal_embryonic_tissue | 0.69323281 |
| 110 | MP0009765_abnormal_xenobiotic_induced | 0.67761656 |
| 111 | MP0003943_abnormal_hepatobiliary_system | 0.67345772 |
| 112 | MP0003045_fibrosis | 0.67075935 |
| 113 | MP0000703_abnormal_thymus_morphology | 0.67022928 |
| 114 | MP0002928_abnormal_bile_duct | 0.66517525 |
| 115 | MP0000579_abnormal_nail_morphology | 0.65071181 |
| 116 | MP0010352_gastrointestinal_tract_polyps | 0.64278082 |
| 117 | MP0001756_abnormal_urination | 0.64166605 |
| 118 | MP0009672_abnormal_birth_weight | 0.63592688 |
| 119 | MP0004947_skin_inflammation | 0.61342557 |
| 120 | MP0005464_abnormal_platelet_physiology | 0.60452997 |
| 121 | MP0005023_abnormal_wound_healing | 0.60224300 |
| 122 | MP0002166_altered_tumor_susceptibility | 0.58311063 |
| 123 | MP0005376_homeostasis/metabolism_phenot | 0.58017522 |
| 124 | MP0002136_abnormal_kidney_physiology | 0.57758501 |
| 125 | MP0003566_abnormal_cell_adhesion | 0.57719965 |
| 126 | MP0009384_cardiac_valve_regurgitation | 0.56136938 |
| 127 | MP0003436_decreased_susceptibility_to | 0.54667540 |
| 128 | MP0009115_abnormal_fat_cell | 0.53514468 |
| 129 | MP0001661_extended_life_span | 0.53245346 |
| 130 | MP0005248_abnormal_Harderian_gland | 0.52242939 |
| 131 | MP0001915_intracranial_hemorrhage | 0.51953048 |
| 132 | MP0005076_abnormal_cell_differentiation | 0.51677861 |
| 133 | MP0000427_abnormal_hair_cycle | 0.51368101 |
| 134 | MP0005395_other_phenotype | 0.51149224 |
| 135 | MP0001881_abnormal_mammary_gland | 0.50415596 |
| 136 | MP0000377_abnormal_hair_follicle | 0.50195821 |
| 137 | MP0005266_abnormal_metabolism | 0.49246482 |
| 138 | MP0002168_other_aberrant_phenotype | 0.48065482 |
| 139 | MP0001243_abnormal_dermal_layer | 0.47089727 |
| 140 | MP0001216_abnormal_epidermal_layer | 0.47035667 |
| 141 | MP0010678_abnormal_skin_adnexa | 0.46223473 |
| 142 | MP0005448_abnormal_energy_balance | 0.45100457 |
| 143 | MP0005058_abnormal_lysosome_morphology | 0.43557878 |
| 144 | MP0008961_abnormal_basal_metabolism | 0.42895172 |
| 145 | MP0005275_abnormal_skin_tensile | 0.42120476 |
| 146 | MP0006036_abnormal_mitochondrial_physio | 0.41537621 |
| 147 | MP0005166_decreased_susceptibility_to | 0.41427834 |
| 148 | MP0002970_abnormal_white_adipose | 0.40921262 |
| 149 | MP0005501_abnormal_skin_physiology | 0.40833538 |
| 150 | MP0004782_abnormal_surfactant_physiolog | 0.40718766 |
| 151 | MP0002098_abnormal_vibrissa_morphology | 0.40686872 |
| 152 | MP0005084_abnormal_gallbladder_morpholo | 0.40407144 |
| 153 | MP0003690_abnormal_glial_cell | 0.38162580 |
| 154 | MP0008873_increased_physiological_sensi | 0.38139649 |
| 155 | MP0002269_muscular_atrophy | 0.37847161 |
| 156 | MP0009931_abnormal_skin_appearance | 0.37578195 |
| 157 | MP0000639_abnormal_adrenal_gland | 0.36822681 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.09968097 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.80915291 |
| 3 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.25849774 |
| 4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.09796253 |
| 5 | Xanthomatosis (HP:0000991) | 6.01203079 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 5.91490219 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 5.51212984 |
| 8 | Complement deficiency (HP:0004431) | 5.40551185 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 4.94193357 |
| 10 | Hypolipoproteinemia (HP:0010981) | 4.61086833 |
| 11 | Abnormality of the common coagulation pathway (HP:0010990) | 4.37978598 |
| 12 | Epidermoid cyst (HP:0200040) | 4.37185941 |
| 13 | Joint hemorrhage (HP:0005261) | 4.33324038 |
| 14 | Hyperammonemia (HP:0001987) | 4.26275875 |
| 15 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.21306208 |
| 16 | Hypoalphalipoproteinemia (HP:0003233) | 4.16579694 |
| 17 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.08710894 |
| 18 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.08058657 |
| 19 | Hyperglycinemia (HP:0002154) | 4.04423202 |
| 20 | Abnormality of complement system (HP:0005339) | 4.02527580 |
| 21 | Fat malabsorption (HP:0002630) | 3.92554014 |
| 22 | Ketosis (HP:0001946) | 3.90453151 |
| 23 | Hyperglycinuria (HP:0003108) | 3.79330692 |
| 24 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.66328484 |
| 25 | Abnormality of glycine metabolism (HP:0010895) | 3.65197344 |
| 26 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.65197344 |
| 27 | Hypoglycemic coma (HP:0001325) | 3.64675967 |
| 28 | Myocardial infarction (HP:0001658) | 3.61717289 |
| 29 | Abnormality of methionine metabolism (HP:0010901) | 3.61084128 |
| 30 | Abnormality of the intrinsic pathway (HP:0010989) | 3.60657761 |
| 31 | Hypercholesterolemia (HP:0003124) | 3.53597253 |
| 32 | Abnormality of the fingertips (HP:0001211) | 3.51090546 |
| 33 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.42218780 |
| 34 | Nemaline bodies (HP:0003798) | 3.34728462 |
| 35 | Conjugated hyperbilirubinemia (HP:0002908) | 3.29673071 |
| 36 | Muscle fiber inclusion bodies (HP:0100299) | 3.27775808 |
| 37 | Hepatocellular carcinoma (HP:0001402) | 3.15261478 |
| 38 | Dysmetric saccades (HP:0000641) | 3.13966155 |
| 39 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.13947714 |
| 40 | Exercise-induced myalgia (HP:0003738) | 3.13456163 |
| 41 | Papillary thyroid carcinoma (HP:0002895) | 3.09435273 |
| 42 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.02024985 |
| 43 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.00649283 |
| 44 | Abnormality of nucleobase metabolism (HP:0010932) | 2.97941354 |
| 45 | Hypochromic microcytic anemia (HP:0004840) | 2.97772118 |
| 46 | Hyperbilirubinemia (HP:0002904) | 2.89307803 |
| 47 | Hyperkalemia (HP:0002153) | 2.88946879 |
| 48 | Septate vagina (HP:0001153) | 2.83233175 |
| 49 | Systemic lupus erythematosus (HP:0002725) | 2.81222497 |
| 50 | Ketoacidosis (HP:0001993) | 2.80666897 |
| 51 | Steatorrhea (HP:0002570) | 2.78789700 |
| 52 | Skin nodule (HP:0200036) | 2.76955250 |
| 53 | Abnormality of purine metabolism (HP:0004352) | 2.75802641 |
| 54 | Spontaneous abortion (HP:0005268) | 2.74835387 |
| 55 | Acanthocytosis (HP:0001927) | 2.70420442 |
| 56 | Chromsome breakage (HP:0040012) | 2.69054205 |
| 57 | Spastic diplegia (HP:0001264) | 2.68347888 |
| 58 | Esophageal varix (HP:0002040) | 2.68013770 |
| 59 | Neonatal hypoglycemia (HP:0001998) | 2.65554574 |
| 60 | Acute myeloid leukemia (HP:0004808) | 2.62863167 |
| 61 | Abnormality of serum amino acid levels (HP:0003112) | 2.56962336 |
| 62 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.56599522 |
| 63 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.52782943 |
| 64 | Mitral stenosis (HP:0001718) | 2.49457337 |
| 65 | Vascular calcification (HP:0004934) | 2.45769222 |
| 66 | Glomerulonephritis (HP:0000099) | 2.44123935 |
| 67 | Malnutrition (HP:0004395) | 2.43300512 |
| 68 | Gout (HP:0001997) | 2.43275560 |
| 69 | Subaortic stenosis (HP:0001682) | 2.42651815 |
| 70 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.42651815 |
| 71 | Delayed CNS myelination (HP:0002188) | 2.40634525 |
| 72 | Cholelithiasis (HP:0001081) | 2.37272045 |
| 73 | Abnormality of the salivary glands (HP:0010286) | 2.36921934 |
| 74 | Progressive muscle weakness (HP:0003323) | 2.36281185 |
| 75 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.34998818 |
| 76 | Abnormal gallbladder morphology (HP:0012437) | 2.32526240 |
| 77 | Metabolic acidosis (HP:0001942) | 2.32316147 |
| 78 | Cardiovascular calcification (HP:0011915) | 2.25963446 |
| 79 | Paralysis (HP:0003470) | 2.23237522 |
| 80 | Poikilocytosis (HP:0004447) | 2.22954463 |
| 81 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.22287848 |
| 82 | Hypoglycemic seizures (HP:0002173) | 2.21779543 |
| 83 | Anal stenosis (HP:0002025) | 2.21283049 |
| 84 | Lip pit (HP:0100267) | 2.21081466 |
| 85 | Gingival bleeding (HP:0000225) | 2.20693636 |
| 86 | Abnormality of nail color (HP:0100643) | 2.17402622 |
| 87 | Osteomalacia (HP:0002749) | 2.16975024 |
| 88 | Hemorrhage of the eye (HP:0011885) | 2.16433700 |
| 89 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.14626455 |
| 90 | Neonatal onset (HP:0003623) | 2.12375834 |
| 91 | Birth length less than 3rd percentile (HP:0003561) | 2.10727355 |
| 92 | Thrombophlebitis (HP:0004418) | 2.10116479 |
| 93 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.08080100 |
| 94 | Dicarboxylic aciduria (HP:0003215) | 2.08080100 |
| 95 | Hyperglycemia (HP:0003074) | 2.08076992 |
| 96 | Curly hair (HP:0002212) | 2.07724073 |
| 97 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.05508164 |
| 98 | Sensorimotor neuropathy (HP:0007141) | 2.05468464 |
| 99 | Ankyloglossia (HP:0010296) | 2.05452358 |
| 100 | Late onset (HP:0003584) | 2.05289937 |
| 101 | Menorrhagia (HP:0000132) | 2.02935191 |
| 102 | Thyroid carcinoma (HP:0002890) | 2.02922155 |
| 103 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.02546227 |
| 104 | Flat acetabular roof (HP:0003180) | 2.01967741 |
| 105 | Cholecystitis (HP:0001082) | 2.01509648 |
| 106 | Abnormal gallbladder physiology (HP:0012438) | 2.01509648 |
| 107 | Germ cell neoplasia (HP:0100728) | 2.01211238 |
| 108 | Abnormality of proline metabolism (HP:0010907) | 2.01082569 |
| 109 | Hydroxyprolinuria (HP:0003080) | 2.01082569 |
| 110 | Fair hair (HP:0002286) | 2.00476850 |
| 111 | Asymmetry of the thorax (HP:0001555) | 1.99941342 |
| 112 | Gastrointestinal carcinoma (HP:0002672) | 1.98823238 |
| 113 | Malignant gastrointestinal tract tumors (HP:0006749) | 1.98823238 |
| 114 | Embryonal renal neoplasm (HP:0011794) | 1.98473618 |
| 115 | Seborrheic dermatitis (HP:0001051) | 1.97813908 |
| 116 | Nephritis (HP:0000123) | 1.94344205 |
| 117 | Amyloidosis (HP:0011034) | 1.94260300 |
| 118 | Abnormal cartilage morphology (HP:0002763) | 1.93975223 |
| 119 | Abnormality of reticulocytes (HP:0004312) | 1.93854324 |
| 120 | Macroorchidism (HP:0000053) | 1.93441107 |
| 121 | Hepatoblastoma (HP:0002884) | 1.92028380 |
| 122 | Irritability (HP:0000737) | 1.90805176 |
| 123 | Pseudobulbar signs (HP:0002200) | 1.90264467 |
| 124 | Deep philtrum (HP:0002002) | 1.89462000 |
| 125 | Bowel incontinence (HP:0002607) | 1.89041374 |
| 126 | Pancreatitis (HP:0001733) | 1.88895181 |
| 127 | Polycythemia (HP:0001901) | 1.88774548 |
| 128 | Reticulocytosis (HP:0001923) | 1.88065803 |
| 129 | Abnormality of the gallbladder (HP:0005264) | 1.88055613 |
| 130 | Back pain (HP:0003418) | 1.85946269 |
| 131 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.85841847 |
| 132 | Sandal gap (HP:0001852) | 1.85661633 |
| 133 | Long clavicles (HP:0000890) | 1.84987616 |
| 134 | Sparse lateral eyebrow (HP:0005338) | 1.84953361 |
| 135 | Progressive external ophthalmoplegia (HP:0000590) | 1.84297119 |
| 136 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.83089359 |
| 137 | Abnormality of the Achilles tendon (HP:0005109) | 1.83078118 |
| 138 | Lethargy (HP:0001254) | 1.81031230 |
| 139 | Multiple enchondromatosis (HP:0005701) | 1.80783947 |
| 140 | Advanced eruption of teeth (HP:0006288) | 1.80603017 |
| 141 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.80410760 |
| 142 | Abnormality of iron homeostasis (HP:0011031) | 1.79895440 |
| 143 | Increased mean platelet volume (HP:0011877) | 1.79345837 |
| 144 | Difficulty running (HP:0009046) | 1.79134746 |
| 145 | Abnormality of the nasal septum (HP:0000419) | 1.78702941 |
| 146 | Heterotopia (HP:0002282) | 1.78118715 |
| 147 | Low anterior hairline (HP:0000294) | 1.77908470 |
| 148 | Right ventricular cardiomyopathy (HP:0011663) | 1.76216496 |
| 149 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.74484038 |
| 150 | Abnormal large intestine physiology (HP:0012700) | 1.73355116 |
| 151 | Biliary tract neoplasm (HP:0100574) | 1.73141400 |
| 152 | Exercise-induced muscle cramps (HP:0003710) | 1.72597863 |
| 153 | Upper motor neuron abnormality (HP:0002127) | 1.72323124 |
| 154 | Alopecia of scalp (HP:0002293) | 1.72263802 |
| 155 | Rickets (HP:0002748) | 1.71813665 |
| 156 | Increased purine levels (HP:0004368) | 1.71046197 |
| 157 | Hyperuricemia (HP:0002149) | 1.71046197 |
| 158 | Rectal prolapse (HP:0002035) | 1.70300976 |
| 159 | Pigmentary retinal degeneration (HP:0001146) | 1.70262829 |
| 160 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.69407913 |
| 161 | Cystic hygroma (HP:0000476) | 1.69074388 |
| 162 | Subacute progressive viral hepatitis (HP:0006572) | 1.68893887 |
| 163 | Calf muscle hypertrophy (HP:0008981) | 1.68081137 |
| 164 | EMG: myopathic abnormalities (HP:0003458) | 1.66826317 |
| 165 | Coarse hair (HP:0002208) | 1.66454897 |
| 166 | Long eyelashes (HP:0000527) | 1.66350663 |
| 167 | Depressed nasal tip (HP:0000437) | 1.66042277 |
| 168 | Abnormality of homocysteine metabolism (HP:0010919) | 1.64703504 |
| 169 | Homocystinuria (HP:0002156) | 1.64703504 |
| 170 | Leiomyosarcoma (HP:0100243) | 1.62929799 |
| 171 | Uterine leiomyosarcoma (HP:0002891) | 1.62929799 |
| 172 | Type 1 muscle fiber predominance (HP:0003803) | 1.62425059 |
| 173 | Increased connective tissue (HP:0009025) | 1.61613618 |
| 174 | Persistence of primary teeth (HP:0006335) | 1.59600264 |
| 175 | Cafe-au-lait spot (HP:0000957) | 1.59549840 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 3.88025698 |
| 2 | BCKDK | 3.83600258 |
| 3 | SIK1 | 3.65323113 |
| 4 | LATS1 | 3.44330599 |
| 5 | FGFR4 | 3.43428603 |
| 6 | PKN2 | 3.16218726 |
| 7 | TRIB3 | 3.15891606 |
| 8 | TAOK3 | 2.92825470 |
| 9 | OBSCN | 2.74985451 |
| 10 | SMG1 | 2.21436313 |
| 11 | EIF2AK1 | 2.14908098 |
| 12 | BRD4 | 2.13934563 |
| 13 | PTK6 | 2.13688389 |
| 14 | MAP3K10 | 2.09999477 |
| 15 | FRK | 2.01288253 |
| 16 | RIPK1 | 1.92414729 |
| 17 | PRPF4B | 1.91302099 |
| 18 | INSRR | 1.78377396 |
| 19 | ERBB4 | 1.77590102 |
| 20 | TYK2 | 1.66753003 |
| 21 | CAMK1D | 1.65002982 |
| 22 | TTK | 1.64091000 |
| 23 | MST1R | 1.58036664 |
| 24 | EEF2K | 1.55227398 |
| 25 | NEK9 | 1.53996133 |
| 26 | CDK12 | 1.53957820 |
| 27 | MAPK11 | 1.51607782 |
| 28 | TRPM7 | 1.48903258 |
| 29 | WNK1 | 1.48660305 |
| 30 | CDK6 | 1.47825032 |
| 31 | FLT3 | 1.45417820 |
| 32 | STK24 | 1.44205203 |
| 33 | NLK | 1.33897815 |
| 34 | MAP3K7 | 1.33564282 |
| 35 | MAP2K3 | 1.33465122 |
| 36 | STK38L | 1.31142752 |
| 37 | TTN | 1.28882886 |
| 38 | STK3 | 1.23653778 |
| 39 | MAP3K3 | 1.23029570 |
| 40 | TGFBR2 | 1.22589990 |
| 41 | JAK2 | 1.22355818 |
| 42 | JAK1 | 1.22042554 |
| 43 | FGFR3 | 1.16638846 |
| 44 | CAMK1G | 1.12954256 |
| 45 | EPHB1 | 1.12057619 |
| 46 | PIK3CG | 1.10858738 |
| 47 | MAP2K4 | 1.10855471 |
| 48 | EPHA3 | 1.10454632 |
| 49 | MAP3K13 | 1.09215483 |
| 50 | FGFR2 | 1.05592076 |
| 51 | PRKAA2 | 1.05382450 |
| 52 | CDC7 | 1.04608283 |
| 53 | MTOR | 1.02196370 |
| 54 | BRSK2 | 1.00043789 |
| 55 | STK10 | 0.95734105 |
| 56 | SGK3 | 0.93496166 |
| 57 | ERBB2 | 0.91821986 |
| 58 | DMPK | 0.91067789 |
| 59 | CDK4 | 0.90791579 |
| 60 | PIM1 | 0.88391025 |
| 61 | KSR2 | 0.88130670 |
| 62 | TSSK6 | 0.87723936 |
| 63 | PDGFRA | 0.84038522 |
| 64 | GRK6 | 0.83666463 |
| 65 | MKNK2 | 0.83359814 |
| 66 | LATS2 | 0.83101488 |
| 67 | CHEK1 | 0.82862048 |
| 68 | ACVR1B | 0.81085646 |
| 69 | CDK7 | 0.80556332 |
| 70 | RPS6KB1 | 0.78320852 |
| 71 | PRKAA1 | 0.77004538 |
| 72 | TBK1 | 0.74953346 |
| 73 | RIPK4 | 0.73373267 |
| 74 | CSF1R | 0.72634970 |
| 75 | MAP3K2 | 0.70783084 |
| 76 | TAF1 | 0.70505028 |
| 77 | PTK2 | 0.70047492 |
| 78 | ATM | 0.69761628 |
| 79 | EPHA2 | 0.69318967 |
| 80 | RET | 0.68933228 |
| 81 | DAPK2 | 0.68280993 |
| 82 | MET | 0.66862592 |
| 83 | MAP3K9 | 0.65399168 |
| 84 | CLK1 | 0.65255310 |
| 85 | YES1 | 0.65049583 |
| 86 | MAP4K1 | 0.64573392 |
| 87 | LRRK2 | 0.63962170 |
| 88 | MAP3K14 | 0.63548770 |
| 89 | CSK | 0.61020492 |
| 90 | PIK3CA | 0.60816855 |
| 91 | ATR | 0.59694211 |
| 92 | BMX | 0.59669301 |
| 93 | MKNK1 | 0.59361741 |
| 94 | NUAK1 | 0.58318617 |
| 95 | CHEK2 | 0.57278782 |
| 96 | GSK3A | 0.57248263 |
| 97 | ABL2 | 0.57219054 |
| 98 | NEK6 | 0.57054734 |
| 99 | ALK | 0.56537914 |
| 100 | TAOK1 | 0.56227454 |
| 101 | SGK1 | 0.55597217 |
| 102 | FER | 0.55295989 |
| 103 | DYRK1B | 0.55228728 |
| 104 | AKT3 | 0.55164521 |
| 105 | MARK2 | 0.54902459 |
| 106 | CDK2 | 0.53592386 |
| 107 | JAK3 | 0.53311464 |
| 108 | SGK223 | 0.52150968 |
| 109 | SGK494 | 0.52150968 |
| 110 | SGK2 | 0.52087194 |
| 111 | PDK2 | 0.50963803 |
| 112 | STK38 | 0.50487961 |
| 113 | ICK | 0.49930386 |
| 114 | CDK1 | 0.49618608 |
| 115 | NEK1 | 0.49161367 |
| 116 | PBK | 0.49108484 |
| 117 | MAPK10 | 0.48660663 |
| 118 | PASK | 0.48655090 |
| 119 | KDR | 0.47928669 |
| 120 | CHUK | 0.47752632 |
| 121 | SRPK1 | 0.47663449 |
| 122 | MAP3K8 | 0.47165400 |
| 123 | PNCK | 0.46882863 |
| 124 | MAP3K6 | 0.46492578 |
| 125 | CDK9 | 0.44719735 |
| 126 | EIF2AK3 | 0.44476710 |
| 127 | KSR1 | 0.44078626 |
| 128 | MAPK12 | 0.43927869 |
| 129 | SCYL2 | 0.43869931 |
| 130 | PDPK1 | 0.43490603 |
| 131 | MAPKAPK3 | 0.42509818 |
| 132 | FGFR1 | 0.42082853 |
| 133 | PDGFRB | 0.41541227 |
| 134 | MAP2K1 | 0.41477653 |
| 135 | TEC | 0.41164504 |
| 136 | EGFR | 0.40730485 |
| 137 | MAP3K1 | 0.39971856 |
| 138 | PLK4 | 0.39835343 |
| 139 | GSK3B | 0.39674856 |
| 140 | RAF1 | 0.38442006 |
| 141 | PDK1 | 0.36562443 |
| 142 | PRKACG | 0.35531499 |
| 143 | PRKCZ | 0.35407070 |
| 144 | PAK2 | 0.34854104 |
| 145 | MAPK4 | 0.34750762 |
| 146 | MELK | 0.34523029 |
| 147 | IGF1R | 0.33354950 |
| 148 | MAP3K5 | 0.32900649 |
| 149 | STK4 | 0.31959859 |
| 150 | MAP3K11 | 0.31653910 |
| 151 | MAPK7 | 0.31222505 |
| 152 | RPS6KB2 | 0.30910474 |
| 153 | ZAP70 | 0.30684854 |
| 154 | NEK2 | 0.30151702 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.32528570 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.82183155 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.47398650 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.40480136 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.13346769 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.77045932 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.66426324 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.58598634 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.55314918 |
| 10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.35891516 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.32654028 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.29401390 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.20273254 |
| 14 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.98441943 |
| 15 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.96452664 |
| 16 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.91428164 |
| 17 | Thyroid cancer_Homo sapiens_hsa05216 | 1.89939464 |
| 18 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.88175263 |
| 19 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.87871090 |
| 20 | Peroxisome_Homo sapiens_hsa04146 | 1.87603516 |
| 21 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.83864644 |
| 22 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.82854187 |
| 23 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.78191129 |
| 24 | Histidine metabolism_Homo sapiens_hsa00340 | 1.75453123 |
| 25 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.71387978 |
| 26 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.68780018 |
| 27 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.68483730 |
| 28 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.66771710 |
| 29 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.65372728 |
| 30 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.65124722 |
| 31 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.63318378 |
| 32 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.62589133 |
| 33 | Bile secretion_Homo sapiens_hsa04976 | 1.58379535 |
| 34 | Retinol metabolism_Homo sapiens_hsa00830 | 1.53686290 |
| 35 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.53515254 |
| 36 | Prostate cancer_Homo sapiens_hsa05215 | 1.47334254 |
| 37 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.43341363 |
| 38 | Cell cycle_Homo sapiens_hsa04110 | 1.42310743 |
| 39 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.40332991 |
| 40 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.39471442 |
| 41 | ABC transporters_Homo sapiens_hsa02010 | 1.35253948 |
| 42 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.34130851 |
| 43 | Lysine degradation_Homo sapiens_hsa00310 | 1.31343668 |
| 44 | Endometrial cancer_Homo sapiens_hsa05213 | 1.31286256 |
| 45 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.25300060 |
| 46 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.24636675 |
| 47 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.23200018 |
| 48 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.22781480 |
| 49 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.22548455 |
| 50 | Circadian rhythm_Homo sapiens_hsa04710 | 1.20360084 |
| 51 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.18410467 |
| 52 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.16746190 |
| 53 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.15647811 |
| 54 | Carbon metabolism_Homo sapiens_hsa01200 | 1.14938953 |
| 55 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.14891723 |
| 56 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.10904209 |
| 57 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.10393191 |
| 58 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.07801516 |
| 59 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.04098341 |
| 60 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.01227327 |
| 61 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.00095500 |
| 62 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.00080536 |
| 63 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.99025593 |
| 64 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.98377464 |
| 65 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.94332683 |
| 66 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.93555789 |
| 67 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.91495655 |
| 68 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.88976439 |
| 69 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.87201230 |
| 70 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.86138917 |
| 71 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.85793093 |
| 72 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.83310994 |
| 73 | RNA transport_Homo sapiens_hsa03013 | 0.83036227 |
| 74 | DNA replication_Homo sapiens_hsa03030 | 0.80011425 |
| 75 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.79407992 |
| 76 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.77996845 |
| 77 | Glioma_Homo sapiens_hsa05214 | 0.76720421 |
| 78 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.76208113 |
| 79 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.75738097 |
| 80 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.75017327 |
| 81 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.74686891 |
| 82 | Sulfur relay system_Homo sapiens_hsa04122 | 0.72970541 |
| 83 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.72488174 |
| 84 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.70203355 |
| 85 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.70047440 |
| 86 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.69848924 |
| 87 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.69841564 |
| 88 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.69787528 |
| 89 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.67709446 |
| 90 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.65779187 |
| 91 | Colorectal cancer_Homo sapiens_hsa05210 | 0.65530364 |
| 92 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.61434989 |
| 93 | Insulin resistance_Homo sapiens_hsa04931 | 0.61119393 |
| 94 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.60456027 |
| 95 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.59563916 |
| 96 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.58694257 |
| 97 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.57643603 |
| 98 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.56815410 |
| 99 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.56366606 |
| 100 | Hepatitis B_Homo sapiens_hsa05161 | 0.55057608 |
| 101 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.53460310 |
| 102 | Spliceosome_Homo sapiens_hsa03040 | 0.53411482 |
| 103 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.49469059 |
| 104 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.47578532 |
| 105 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.43526817 |
| 106 | Galactose metabolism_Homo sapiens_hsa00052 | 0.37447835 |
| 107 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.32781042 |
| 108 | Prion diseases_Homo sapiens_hsa05020 | 0.28824553 |
| 109 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.26792016 |
| 110 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.25446000 |
| 111 | Metabolic pathways_Homo sapiens_hsa01100 | 0.25092918 |
| 112 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.15755738 |
| 113 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.15728253 |
| 114 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.13782183 |
| 115 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.11486745 |
| 116 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.05361471 |
| 117 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.03916184 |
| 118 | Bladder cancer_Homo sapiens_hsa05219 | 0.03527907 |
| 119 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.02814070 |
| 120 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.01665436 |
| 121 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.00862049 |
| 122 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.00783120 |
| 123 | Hepatitis C_Homo sapiens_hsa05160 | 0.00753873 |
| 124 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.00624606 |
| 125 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.00265154 |
| 126 | Acute myeloid leukemia_Homo sapiens_hsa05221 | -0.1010391 |
| 127 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | -0.0961213 |
| 128 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0896956 |
| 129 | Non-small cell lung cancer_Homo sapiens_hsa05223 | -0.0859434 |
| 130 | FoxO signaling pathway_Homo sapiens_hsa04068 | -0.0814169 |
| 131 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.0805846 |
| 132 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0696812 |
| 133 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.0393410 |
| 134 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0391530 |
| 135 | Adherens junction_Homo sapiens_hsa04520 | -0.0138972 |
| 136 | Amoebiasis_Homo sapiens_hsa05146 | -0.0066077 |

